Vyome Holdings, Inc. (HIND) vs Lipocine Inc. (LPCN)
- Vyome Holdings, Inc. HIND 1.87 −2.09%
- Lipocine Inc. LPCN 1.56 −7.14%
Vyome Holdings, Inc. and Lipocine Inc. are both Biotechnology companies. Vyome Holdings, Inc. and Lipocine Inc. are of similar size ($13.9M and $13.4M). Lipocine Inc. has negative trailing earnings, so its P/E is not meaningful; Vyome Holdings, Inc. trades at 0.0×. Vyome Holdings, Inc. grew revenue faster over the last twelve months: 103.8% against −63.5%. Lipocine Inc. has the higher net margin (−755.1% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Lipocine Inc. leads on 11 and Vyome Holdings, Inc. on 5.
Valuation
Profitability
| Metric | HIND | LPCN | Biotechnology median |
|---|---|---|---|
| Gross margin | 52.77% | 100.00% | 65.16% |
| Operating margin | (9,184.82%) | (800.80%) | 0.00% |
| Net margin | (8,711.71%) | (755.11%) | 0.00% |
| Free cash flow margin | (4,298.00%) | (713.02%) | 0.00% |
| Return on equity | (172.10%) | (60.94%) | (56.36%) |
| Return on assets | (124.23%) | (55.89%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack